Clinical Study of the Effectiveness, Tolerability and Safety of the Drug " Anti-spike, Gel, 100 g in Bottles in Package No. 1 " Produced by the Republican Unitary Enterprise " Unitekhprom BSU " , With a Single Intraperitoneal Use After Surgery in Adult Patients With Acute Phlegmonous Appendicitis
Conditions: Abdominal Adhesions Interventions: Drug: Antispike gel, 100 g in a flask, produced by UNITEHPROM BSU, Republic of Belarus; Procedure: antegrade appendectomy Sponsors: Research Institute for Physical Chemical Problems of the Belarusian State University; Unitary Enterprise UNITEHPROM BSU; City Clinical Hospital of Emergency Medical Care of Minsk Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
Assessing the Effectiveness of Continuous Glucose Monitoring in Enhancing Surgical Outcomes for Diabetic Patients
Conditions: Comprehensive Complication Index Interventions: Device: Continuous glucose monitoring (CGM) device Sponsors: Beijing Tsinghua Chang Gung Hospital; Peking University International Hospital; Wang Jing Hospital; ZhuHai Hospital; Beijing Hospital; Siyang County Hospital of Traditional Chinese Medicine; Second Hospital of Shanxi Medical University; Henan Provincial Chest Hospital; Fuzhou First Hospital; Pinggu Hospital of Beijing Traditional Chinese Medicine Hospital; The First Affiliated Hospital of Anhui University of Chinese Medicine; The First Affiliated Hospital of Zhengzhou University; Mindong Hospital of Ning...
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
Study to Actively Warm Trauma Patients-2
Conditions: Trauma Injury; Hypothermia; Massive Hemorrhage Interventions: Other: Ready-Heat Chemical Heating Blankets; Other: Warmed blankets or FAWB Sponsors: Sunnybrook Health Sciences Centre Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials
Socioeconomic Determinants of the Chemical Exposome and Its Genotoxic Effects in Children
Conditions: Healthy Volunteer Children Interventions: Other: Hair cut; Other: Socio-economic questionnaires Sponsors: Institut Cancerologie de l ' Ouest; ANSES Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2024 Category: Research Source Type: clinical trials
Ibuprofen Inhibits Human Sweet Taste
Conditions: Treatment of Sweet Taste Receptors Without or With an Oral Rinse of Ibuprofen Solution in Healthy Participants; Treatment of Sweet Taste Receptors Without or With an Oral Rinse of Naproxen Solution in Healthy Participants Interventions: Drug: Inhibition of Sweet Taste by Ibuprofen Oral Rinses; Drug: Inhibition of Sweet Taste by Naproxen Oral Rinses Sponsors: Rutgers, The State University of New Jersey; Monell Chemical Senses Center Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Infant Sleep and Exposure to Mixture of Chemical Environmental Pollutants
Conditions: Newborn; Chemical Pollutants Exposure; Sleep Interventions: Device: 7-day actimetry sleep recording; Other: Determination of environmental pollutants in breast milk; Other: Measurements of environmental pollutants in indoor air deposited on the bracelet worn by the child; Other: Continuous recording of the child's temperature for 7 days; Other: Use of a sleep diary for 7 days; Other: Parental questionnaire of environmental exposure Sponsors: Centre Hospitalier Universitaire, Amiens Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2024 Category: Research Source Type: clinical trials
SAMe in Prevention of Oxaliplatin-associated Liver Injury
Conditions: Colorectal Cancer; Liver Metastases; Liver Metastasis Colon Cancer; Liver Injury; Sinusoidal Obstruction Syndrome; 5-Fluorouracil Toxicity; Liver Toxicity, Chemically-Induced Interventions: Radiation: Standard of care oxaliplatin-based chemotherapy; Dietary Supplement: S-adenosylmethionine (SAMe) supplement; Procedure: Surgery Sponsors: Cedars-Sinai Medical Center; Jarrow Formulas Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials
Clinical Study of the Medicinal Product " Foscelantan, Medicinal Plate 4.0x5.0 cm in Package No. 1 " Produced by UNITEHPROM BSU, in Adult Patients With Purulent-inflammatory Processes of the Skin and Soft Tissues, Phase I-II of the Wound Process
Conditions: Diabetic Foot Infections; Chronic Venous Insufficiency Interventions: Drug: Foscelantan; Drug: Povidon-iodine Sponsors: Research Institute for Physical Chemical Problems of the Belarusian State University; Vitebsk Regional Clinical Hospital; Unitary Enterprise UNITEHPROM BSU; The 10th Minsk City Clinical Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials
An Open Prospective Randomized Clinical Study of the Effectiveness, Tolerability and Safety of a Single Intraperitoneal Use of the Drug " Prospidelong, Powder for the Preparation of a Gel for Topical Use, 1000 mg in Vials, Package No. 1 " in Patients With Disseminated Gastric Cancer, Phase I-II
Conditions: Gastric Cancer With Peritoneal Dissemination Interventions: Drug: Prospidelong; Procedure: chemotherapy Sponsors: Research Institute for Physical Chemical Problems of the Belarusian State University; The state institution N. N. Alexandrov National Cancer Centre of Belarus; Unitary Enterprise UNITEHPROM BSU Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials
Investigating the Effect of a Single-dose of Levetiracetam on Brain Function, Chemistry and Cognitive Performance in Psychosis Risk
Conditions: Psychosis Interventions: Drug: Levetiracetam; Drug: Placebo Sponsors: King ' s College London Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Ensysce Biosciences Announces FDA Breakthrough Therapy Designation Granted for PF614-MPAR
SAN DIEGO, CA / ACCESSWIRE / January 23, 2024 / Ensysce Biosciences, Inc. ( " Ensysce " or the " Company " ) (NASDAQ:ENSC), a clinical-stage company applying transformative chemistry to improve prescription drug safety, today announced receipt of notice... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - January 23, 2024 Category: Pharmaceuticals Source Type: clinical trials
Investigation Into the Pathophysiology and Treatment of Varicose Veins
Conditions: Varicose Veins Interventions: Procedure: Chemical sclerotherapy; Drug: 1% Sodium Tetradecyl Sulphate; Drug: 3% Sodium Tetradecyl Sulphate; Drug: 0.5% Polidocanol; Drug: 3% Polidcanol Sponsors: University of Surrey; The Whiteley Clinic Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials
Investigating the Role of Diazepam on Brain Function and Chemistry in Psychosis Risk
Conditions: Prodromal Schizophrenia Interventions: Drug: Diazepam 5 Mg Oral Tablet; Drug: Ascorbic Acid 50 Mg Oral Tablet Sponsors: King ' s College London; Wellcome Trust; The Royal Society Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 4, 2024 Category: Research Source Type: clinical trials
Exposure to Chemical Substances Within Household Waste Incineration Plants
Conditions: Exposure to Chemical Pollution, Occupational Sponsors: University Hospital, Strasbourg, France Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 28, 2023 Category: Research Source Type: clinical trials
Predicting the Response of Patients With Rheumatoid Arthritis to Treatment With Genetically Engineered Biological Drugs and Janus (JAK) Kinase Inhibitors
Conditions: Rheumatoid Arthritis Interventions: Drug: genetically engineered biological drugs, Janus-kinase inhibitors, tumor necrosis factor inhibitors Sponsors: Institute of Biomedical Chemistry, Russia; Moscow Regional Research and Clinical Institute Moniki n.a. M.F. Vladimirskiy Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 20, 2023 Category: Research Source Type: clinical trials
